Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy

Lameck Masina

   BLANTYRE - Malawi's President Lazarus Chakwera says the country will go
   ahead with acquiring the AstraZeneca COVID-19 vaccine, despite concerns
   about its efficacy. Chakwera on Sunday evening announced Malawi has
   acquired 1.5 million doses and that additional ones were on the way to
   vaccinate a total of about four and a half million people. Chakwera
   said Malawi, one of Africa's poorest countries, settled for the
   AstraZeneca vaccine because it is cheaper.

   In a televised address on the fight against COVID-19, President
   Chakwera said the vaccine type coming to Malawi has an average of 60 to
   70 percent efficacy.

.